Common Joint Pain Supplement May Increase Alzheimer’s Risk

## Study Overview A new investigation published on June 18, 2026 in Nature Metabolism examined whether glucosamine—a supplement frequently taken for joint pain and osteoarthritis—might influence the progression of Alzheimer’s disease and related cognitive disorders.

### Population and Methodology The researchers performed a retrospective analysis of medical records for approximately 24,000 individuals diagnosed with dementia and more than 41,000 people with mild cognitive impairment. Participants were divided into two groups: those who reported regular glucosamine use and those who did not.

### Key Findings - Mortality: Alzheimer’s patients who took glucosamine faced a 25 % higher risk of death within five years compared with non‑users in the same cohort. - Disease Progression: Among individuals in the early stages of cognitive decline, glucosamine users showed a similar increase in the likelihood of advancing to full‑blown Alzheimer’s disease. - Animal Experiments: Parallel studies on genetically modified mice that mimic Alzheimer’s pathology revealed that glucosamine administration exacerbated memory loss, whereas inhibiting the enzyme responsible for producing glucosamine‑like sugars ameliorated symptoms.

## Potential Biological Mechanism The authors suggest that glucosamine may promote the accumulation of sugar chains on proteins and neurons—a process known as non‑enzymatic glycation or “glycation overload.” This buildup can damage cells and impair memory functions in Alzheimer’s patients.

## Limitations and Future Research The investigators caution that the study does not prove a direct causal relationship because it relies on observational medical records rather than randomized clinical trials. Uncertainties remain regarding: - The impact of dosage, duration of use, or specific glucosamine formulations. - Whether the supplement’s effects differ based on an individual’s existing health status. Future work will track patients who discontinue glucosamine to see if cognitive decline slows, and will explore other supplements with similar metabolic pathways.

## Conclusion While the findings raise important questions about the safety of glucosamine for individuals with existing memory problems or dementia, they are not definitive. Health professionals advise patients to discuss supplement use with their physicians, especially if they have cognitive concerns.

Edited by Mohamed Farhan